Nov. 11, 2019 Price forecast | 2 weeks: -1.47% | 1 month: -3.65% | 3 months: -18.87%


RSLS stock forecast

Our latest prediction for ReShape Lifesciences, Inc.'s stock price was made on the Nov. 11, 2019 when the stock price was at 7.32$.

In the short term (2weeks), RSLS's stock price should underperform the market by -1.47%. During that period the price should oscillate between -14.66% and +12.13%.

In the medium term (3months), RSLS's stock price should underperform the market by -18.87%. During that period the price should oscillate between -39.38% and +25.85%.


About ReShape Lifesciences, Inc.

ReShape Lifesciences Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded on December 2002 and is headquartered in San Clemente, CA.

At the moment the company generates 11M USD in revenues.

On its last earning announcement, the company reported a profit of 2231.11$ per share.

The book value per share is 0.64$

ReShape Lifesciences, Inc. website


Three months stock forecastNov. 11, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
11M 65.80% -17M -151.19% -77M 2231.11 - - - 0.64 -20M - -20M